LQDA
LQDA
NASDAQ · Pharmaceuticals

Liquidia Corp

$36.61
+1.41 (+4.01%)
Financial Highlights (FY 2026)
Revenue
12.60M
Net Income
-117,369,792
Gross Margin
58.0%
Profit Margin
-931.7%
Rev Growth
+2.9%
D/E Ratio
1.49
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 58.0% 58.0% 52.5% 52.5%
Operating Margin -897.1% -807.4% 26.8% 26.1%
Profit Margin -931.7% -885.1% 19.2% 19.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.60M 12.24M 783.80M 707.55M
Gross Profit 7.31M 7.10M 411.26M 371.25M
Operating Income -113,005,500 -98,848,235 210.20M 184.67M
Net Income -117,369,792 -102,665,771 150.56M 137.41M
Gross Margin 58.0% 58.0% 52.5% 52.5%
Operating Margin -897.1% -807.4% 26.8% 26.1%
Profit Margin -931.7% -885.1% 19.2% 19.4%
Rev Growth +2.9% +2.9% +0.6% +0.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 913.17M 913.17M 962.93M 1.24B
Total Equity 611.43M 611.43M 1.27B 1.28B
D/E Ratio 1.49 1.49 0.76 0.97
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -112,941,947 -104,281,125 266.89M 249.48M
Free Cash Flow 76.52M 82.10M